nephrolithiasis

Literature (5)

Literature for DOID 585: nephrolithiasis

Xenbase Articles Publications associated with this Disease Ontology entry or its descendants

:
(

Denotes literature images)

Functional characterization of two naturally occurring mutations in the human sodium-phosphate cotransporter type IIa., Virkki LV,Forster IC,Hernando N,Biber J,Murer H, J Bone Miner Res. December 1, 2003; 18(12):0884-0431.
Species differences in Cl- affinity and in electrogenicity of SLC26A6-mediated oxalate/Cl- exchange correlate with the distinct human and mouse susceptibilities to nephrolithiasis., Clark JS,Vandorpe DH,Chernova MN,Heneghan JF,Stewart AK,Alper SL, J Physiol. March 1, 2008; 586(5):0022-3751.
Regulated transport of sulfate and oxalate by SLC26A2/DTDST., Heneghan JF,Akhavein A,Salas MJ,Shmukler BE,Karniski LP,Vandorpe DH,Alper SL, Am J Physiol Cell Physiol. June 1, 2010; 298(6):1522-1563.
The L530R variation associated with recurrent kidney stones impairs the structure and function of TRPV5., Wang L,Holmes RP,Peng JB, Biochem Biophys Res Commun. October 21, 2017; 492(3):1090-2104.
OXGR1 is a candidate disease gene for human calcium oxalate nephrolithiasis., Majmundar AJ,Widmeier E,Heneghan JF,Daga A,Wu CW,Buerger F,Hugo H,Ullah I,Amar A,Ottlewski I,Braun DA,Jobst-Schwan T,Lawson JA,Zahoor MY,Rodig NM,Tasic V,Nelson CP,Khaliq S,Schönauer R,Halbritter J,Sayer JA,Fathy HM,Baum MA,Shril S,Mane S,Alper SL,Hildebrandt F, Genet Med. March 1, 2023; 25(3):1530-0366.

Functional characterization of two naturally occurring mutations in the human sodium-phosphate cotransporter type IIa., Virkki LV,Forster IC,Hernando N,Biber J,Murer H, J Bone Miner Res. December 1, 2003; 18(12):0884-0431.

Species differences in Cl- affinity and in electrogenicity of SLC26A6-mediated oxalate/Cl- exchange correlate with the distinct human and mouse susceptibilities to nephrolithiasis., Clark JS,Vandorpe DH,Chernova MN,Heneghan JF,Stewart AK,Alper SL, J Physiol. March 1, 2008; 586(5):0022-3751.

Regulated transport of sulfate and oxalate by SLC26A2/DTDST., Heneghan JF,Akhavein A,Salas MJ,Shmukler BE,Karniski LP,Vandorpe DH,Alper SL, Am J Physiol Cell Physiol. June 1, 2010; 298(6):1522-1563.

The L530R variation associated with recurrent kidney stones impairs the structure and function of TRPV5., Wang L,Holmes RP,Peng JB, Biochem Biophys Res Commun. October 21, 2017; 492(3):1090-2104.

OXGR1 is a candidate disease gene for human calcium oxalate nephrolithiasis., Majmundar AJ,Widmeier E,Heneghan JF,Daga A,Wu CW,Buerger F,Hugo H,Ullah I,Amar A,Ottlewski I,Braun DA,Jobst-Schwan T,Lawson JA,Zahoor MY,Rodig NM,Tasic V,Nelson CP,Khaliq S,Schönauer R,Halbritter J,Sayer JA,Fathy HM,Baum MA,Shril S,Mane S,Alper SL,Hildebrandt F, Genet Med. March 1, 2023; 25(3):1530-0366.